abstract |
A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined herein. |